Drugs for depressionr.
Med Lett Drugs Ther
; 65(1691): 193-200, 2023 12 11.
Article
in En
| MEDLINE
| ID: mdl-38133585
Key words
Abilify; Aplenzin; Auvelity; Buspar; Celexa; Cymbalta; Deplin; Effexor; Emsam; Exxua; Fetzima; Forfivo; L-methylfolate; Lexapro; Marplan; Nardil; Norpramin; PamelorZurzuvae; Parnate; Paxil; Pristiq; Prozac; Remeron; SNRIs; SSRIs; Seroquel; Spravato; St. John's wort; Symbyax; Trintellix; Viibryd; Wellbutrin; Zoloft; Zulresso; Zurzuvae; adverse effects; amitriptyline; amoxapine; antipsychotics; aripiprazole; brexanolone; bupropion; buspirone; citalopram; cognitive behavioral therapy; deep brain stimulation; depression; desipramine; desvenlafaxine; dextromethorphan; dosage; drug interactions; duloxetine; efficacy; electroconvulsive therapy; escitalopram; esketamine; fluoxetine; gepirone; imipramine; isocarboxazid; ketamine; lactation; levomilnacipran; lithium; mirtazapine; nefazodone; nortriptyline; olanzapine; paroxetine; phenelzine; pregnancy; psilocybin; quetiapine; safety; selegiline; sertraline; transcranial magnetic stimulation; tranylcypromine; trazodone; tricyclic antidepressants; triiodothyronine; venlafaxine; vilazodone; vortioxetine; zuranolone
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Selective Serotonin Reuptake Inhibitors
/
Antidepressive Agents
Limits:
Humans
Language:
En
Journal:
Med Lett Drugs Ther
Year:
2023
Document type:
Article